{
    "code": "70000038",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=70000038",
    "time": "2024-03-21 21:46:09",
    "許可證字號": "衛部罕藥輸字第000038號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/05\/04",
    "發證\/登錄日期": "106\/05\/04",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA07000003800",
    "中文品名": "歐博捷膜衣錠14毫克",
    "英文品名": "AUBAGIO film coated tablet 14 mg",
    "適應症": "1. 成人復發緩解型多發性硬化症(relapsing-remitting multiple sclerosis, RRMS)。\r\n2. 疑似多發性硬化症之成人臨床單一症候群(clinically isolated syndrome, CIS)。\r\n3. 成人活動性次發進展型多發性硬化症(active secondary progressive multiple sclerosis, active SPMS)。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "111\/05\/04",
    "主成分略述": "Teriflunomide",
    "限制項目": "02輸　入",
    "申請商名稱": "賽諾菲股份有限公司",
    "申請商地址": "台北市信義區松仁路3號7樓",
    "主製造廠": [
        {
            "製造廠名稱": "OPELLA HEALTHCARE INTERNATIONAL SAS",
            "製造廠廠址": "56, ROUTE DE CHOISY, 60200 COMPIEGNE, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "台灣大昌華嘉股份有限公司高上倉",
            "製造廠廠址": "桃園市楊梅區高上路1段150號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "台灣大昌華嘉股份有限公司",
            "製造廠廠址": "桃園市楊梅區梅獅路二段629號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200082900",
            "成分名稱": "Teriflunomide",
            "含量描述": "",
            "含量": "14.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "TW - AUBAGIO14mg_USPI2021-04 approval PI+update package_C_2021-10-29-110-11-22(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000038&Seq=005&Type=9"
        },
        {
            "title": "Attachment 2_AUBAGIO 14mg_LPI_C_USPI2021-04 as per TFDA comment_clean-110-10-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000038&Seq=004&Type=9"
        },
        {
            "title": "R895820 _box (20200225)-109-10-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000038&Seq=005&Type=8"
        },
        {
            "title": "Aubagio-14mg-Wallet-106-07-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000038&Seq=004&Type=8"
        },
        {
            "title": "Aubagio 14mg-Sleeve-106-07-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000038&Seq=003&Type=8"
        },
        {
            "title": "Aubagio 14mg-Chinese sticker-106-07-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000038&Seq=002&Type=8"
        },
        {
            "title": "Aubagio 14mg-Carton-106-07-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=70000038&Seq=001&Type=8"
        }
    ]
}